Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Sun Pharmaceutical Industries Limited
SUNPHARMA | NSE
1,620.40
INR-59.70
-3.55%
SUNPHARMA | NSE
Loading StockChartView...
About Sun Pharmaceutical Industries Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
24/04/2026
Close
1,620.40
Open
1,670.40
High
1,673.30
Low
1,613.60
Sun Pharmaceutical Industries Limited a generic pharmaceutical company develops manufactures and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas including central nervous system dermatology cardiology oncology and ophthalmic neuro-psychiatry gastroenterology anti-infectives diabetology pain/analgesics vitamins/minerals/nutrients respiratory gynaecology urology ophthalmology orthopaedic nephrology dental and other areas. It also provides APIs for anti-cancers peptides steroids sex hormones and controlled substances; generic medications such as tablets capsules injectables inhalers ointments creams and liquids; speciality medications as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai India.
View LessSUNPHARMA | NSE
Risk
26.5
Sharpe
-0.44
Luna's Score
51/100
Recommendation
Hold
Luna says (SUNPHARMA | NSE)
What's Working
Low 6-Month Volatility (<30%)
Largecap (10B - 200B USD)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High Current Volume and Negative 1-Day Return
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
29.8%1 month
26.5%3 months
22.5%6 months
19.6%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
44.06
Fwd. PE
26.95
Price to book
7.12
Debt to equity
0.05
Debt to assets
0.04
Ent. to EBITDA
29.53
Ent. to rev.
9.02
PEG
-
Other Fundamentals
EBITDA
132.03B
MarketCap
3,887.87B
MarketCap(USD)
40.26B
Div. yield
0.71
Op. margin
23.73
Erngs. growth
40.50
Rev. growth
6.00
Ret. on equity
15.20
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
100.30
Range1M
205.40
Range3M
259.30
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
2.46
Price X volume
15.56B
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 29.53 | 24.85 | Par |
| Ent. to Revenue | 9.02 | 11.40 | Cheaper |
| PE Ratio | 44.06 | 51.36 | Par |
| Price to Book | 7.12 | 6.83 | Par |
| Dividend Yield | 0.71 | 0.52 | Leader |
| Std. Deviation (3M) | 22.46 | 42.17 | Lower Risk |
| Debt to Equity | 0.05 | 0.35 | Cheaper |
| Debt to Assets | 0.04 | 0.17 | Cheaper |
| Market Cap | 3,887.87B | 290.82B | Market Leader |
